Publications
-
Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease.
Tseng D,
Rachakonda LP, Su Z, Advani R, Horning S, Hoppe RT, Quon A, Graves EE, Loo BW, Tran PT.
Radiat Oncol.
2012:
7
5
-
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Willingham SB,
Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, Wang J, Contreras-Trujillo H, Martin R, Cohen JD, Lovelace P, Scheeren FA, Chao MP, Weiskopf K, Tang C, Volkmer AK, Naik TJ, Storm TA, Mosley AR, Edris B, Schmid SM, Sun CK, Chua MS, Murillo O, Rajendran P, Cha AC, Chin RK, Kim D, Adorno M, Raveh T, Tseng D, Jaiswal S, Enger PØ, Steinberg GK, Li G, So SK, Majeti R, Harsh GR, van de Rijn M, Teng NN, Sunwoo JB, Alizadeh AA, Clarke MF, Weissman IL.
Proc Natl Acad Sci U S A.
2012;
109
(17):
6662-7
-
Clonally identical Hodgkin's disease develops after allogeneic hematopoietic cell transplant for CLL.
Tseng D,
Jones CD, Anderson M, Warnke R, Zehnder JL, Miklos DB.
Bone Marrow Transplant.
2011;
46
(12):
1576-8
-
Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas.
Tseng D,
Vasquez-Medrano DA, Brown JM.
Br J Cancer.
2011;
104
(12):
1805-9
-
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment.
Ahn GO,
Tseng D, Liao CH, Dorie MJ, Czechowicz A, Brown JM.
Proc Natl Acad Sci U S A.
2010;
107
(18):
8363-8
-
Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma.
Bachireddy P,
Tseng D, Horoschak M, Chang DT, Koong AC, Kapp DS, Tran PT.
Radiat Oncol.
2010:
5
105
-
Cancer stem cell-directed therapies: recent data from the laboratory and clinic.
Park CY,
Tseng D, Weissman IL.
Mol Ther.
2009;
17
(2):
219-30
-
Naive and memory T cells induce different types of graft-versus-host disease.
Dutt S,
Tseng D, Ermann J, George TI, Liu YP, Davis CR, Fathman CG, Strober S.
J Immunol.
2007;
179
(10):
6547-54
-
L-selectin and beta7 integrin on donor CD4 T cells are required for the early migration to host mesenteric lymph nodes and acute colitis of graft-versus-host disease.
Dutt S,
Ermann J, Tseng D, Liu YP, George TI, Fathman CG, Strober S.
Blood.
2005;
106
(12):
4009-15
Help